In addition, we estimated the SPRED3 expression difference in the traditional molecular markers of papillary thyroid cancer such as BRAFV600E-RAS score (BRS), Thyroid differentiation score (TDS) and ERK activation level (i.e., ERK score). This evidence concerns the gene SPRED3 and thyroid gland papillary carcinoma.